From: Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study
 | IADL | BADL | TUG | SPPB |
---|---|---|---|---|
Cardio and cerebrovascular disease OR (IC 95%) | 1.89* (1.17 - 3.03) | 1.23 (0.77 - 1.98) | 0.83 (0.51 - 1.33) | 0.99 (0.62 - 1.59) |
Respiratory disease OR (IC 95%) | 0.39* (0.24 - 0.62) | 0.60* (0.37 - 0.96) | 1.91* (1.19 - 3.06) | 0.54* (0.34 - 0.88) |
Metabolic impairment OR (IC 95%) | 0.95 (0.59 -1.53) | 1.08 (0.67 - 1.74) | 0.60 (0.38 – 0.97) | 1.40 (0.87 - 2.25) |
Goitre OR (IC 95%) | 0.87 (0.54 - 1.40) | 0.78 (0.49 - 1.26) | 0.90 (0.56 - 1.44) | 0.74 (0.46 - 1.19) |
Endocrine dysfunctions OR (IC 95%) | 1.19 (0.74 - 1.91) | 0.34* (0.21 - 0.54) | 0.63* (0.39 - 1.01) | 1.05 (0.65 - 1.69) |
Oncological disease OR (IC 95%) | 1.43 (0.89 - 2.30) | 1.23 (0.77 - 1.98) | 0.85 (0.53 - 1.36) | 1.43 (0.89 - 2.30) |
Digestive diseases OR (IC 95%) | 0.86* (0.54 - 1.39) | 0.85* (0.53 - 1.37) | 1.52* (0.95 - 2.45) | 0.69* (0.43 - 1.10) |
Psychiatric OR (IC 95%) | 0.49 (0.31 - 0.79) | 0.48 (0.30 – 0.77) | 1.08 (0.67 - 1.74) | 0.84 (0.52 - 1.34) |
Musculoskeletal diseases OR (IC 95%) | 0.89 (0.55 - 1.42) | 0.89 (0.56 - 1.44) | 1.73* (1.08 - 2.78) | 0.89 (0.55 - 1.42) |
Bone diseases OR (IC 95%) | 1.03* (0.64 - 1.65) | 1.36* (0.85 - 2.19) | 1.11* (0.69 - 1.79) | 0.67* (0.42 – 1.08) |